Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Aren van Waarde

Showing results (21-30 of 102) with videos related to

Pageof 11
Sort By:
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 17, 2007
Rapid reduction of sigma1-receptor binding and 18F-FDG uptake in rat gliomas after in vivo treatment with doxorubicinAren van Waarde, Kazuhiro Shiba, Johan R de Jong, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 9, 2005
Synthesis and evaluation of dopamine D3 receptor antagonist 11C-GR218231 as PET tracer for P-glycoproteinErik F J de Vries, Rudie Kortekaas, Aren van Waarde, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 30, 2016
Preclinical Evaluation and Quantification of <sup>18</sup>F-Fluoroethyl and <sup>18</sup>F-Fluoropropyl Analogs of SCH442416 as Radioligands for PET Imaging of the Adenosine A<sub>2A</sub> Receptor in Rat BrainShivashankar Khanapur, Aren van Waarde, Rudi A J O Dierckx, et al.
Current Pharmaceutical Design|November 6, 2010
Sigma receptors in oncology: therapeutic and diagnostic applications of sigma ligandsAren van Waarde, Anna A Rybczynska, Nisha Ramakrishnan, et al.
International Journal of Molecular Sciences|February 12, 2021
Allosteric Interactions between Adenosine A<sub>2A</sub> and Dopamine D<sub>2</sub> Receptors in Heteromeric Complexes: Biochemical and Pharmacological Characteristics, and Opportunities for PET ImagingKavya Prasad, Erik F J de Vries, Philip H Elsinga, et al.
Current Pharmaceutical Design|December 17, 2008
Growth factor/peptide receptor imaging for the development of targeted therapy in oncologyChristophe Van de Wiele, Hendricus Boersma, Rudi A Dierckx, et al.
Chest|October 21, 2005
Positron emission tomography studies of human airways using an inhaled beta-adrenoceptor antagonist, S-11C-CGP 12388Aren van Waarde, Bram Maas, Petra Doze, et al.
Medicinal Research Reviews|November 20, 2018
Hunting for the high-affinity state of G-protein-coupled receptors with agonist tracers: Theoretical and practical considerations for positron emission tomography imagingVladimir Shalgunov, Aren van Waarde, Jan Booij, et al.
Biochimica Et Biophysica Acta|September 1, 2014
Potential applications for sigma receptor ligands in cancer diagnosis and therapyAren van Waarde, Anna A Rybczynska, Nisha K Ramakrishnan, et al.
European Journal of Nuclear Medicine and Molecular Imaging|May 11, 2002
Quantification of beta-adrenoceptor density in the human heart with (S)-[11C]CGP 12388 and a tracer kinetic modelPetra Doze, Philip H Elsinga, Aren van Waarde, et al.
Pageof 11

Showing results (21-30 of 102) with videos related to

Sort By:
Pageof 11
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 17, 2007
Rapid reduction of sigma1-receptor binding and 18F-FDG uptake in rat gliomas after in vivo treatment with doxorubicinAren van Waarde, Kazuhiro Shiba, Johan R de Jong, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 9, 2005
Synthesis and evaluation of dopamine D3 receptor antagonist 11C-GR218231 as PET tracer for P-glycoproteinErik F J de Vries, Rudie Kortekaas, Aren van Waarde, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 30, 2016
Preclinical Evaluation and Quantification of <sup>18</sup>F-Fluoroethyl and <sup>18</sup>F-Fluoropropyl Analogs of SCH442416 as Radioligands for PET Imaging of the Adenosine A<sub>2A</sub> Receptor in Rat BrainShivashankar Khanapur, Aren van Waarde, Rudi A J O Dierckx, et al.
Current Pharmaceutical Design|November 6, 2010
Sigma receptors in oncology: therapeutic and diagnostic applications of sigma ligandsAren van Waarde, Anna A Rybczynska, Nisha Ramakrishnan, et al.
International Journal of Molecular Sciences|February 12, 2021
Allosteric Interactions between Adenosine A<sub>2A</sub> and Dopamine D<sub>2</sub> Receptors in Heteromeric Complexes: Biochemical and Pharmacological Characteristics, and Opportunities for PET ImagingKavya Prasad, Erik F J de Vries, Philip H Elsinga, et al.
Current Pharmaceutical Design|December 17, 2008
Growth factor/peptide receptor imaging for the development of targeted therapy in oncologyChristophe Van de Wiele, Hendricus Boersma, Rudi A Dierckx, et al.
Chest|October 21, 2005
Positron emission tomography studies of human airways using an inhaled beta-adrenoceptor antagonist, S-11C-CGP 12388Aren van Waarde, Bram Maas, Petra Doze, et al.
Medicinal Research Reviews|November 20, 2018
Hunting for the high-affinity state of G-protein-coupled receptors with agonist tracers: Theoretical and practical considerations for positron emission tomography imagingVladimir Shalgunov, Aren van Waarde, Jan Booij, et al.
Biochimica Et Biophysica Acta|September 1, 2014
Potential applications for sigma receptor ligands in cancer diagnosis and therapyAren van Waarde, Anna A Rybczynska, Nisha K Ramakrishnan, et al.
European Journal of Nuclear Medicine and Molecular Imaging|May 11, 2002
Quantification of beta-adrenoceptor density in the human heart with (S)-[11C]CGP 12388 and a tracer kinetic modelPetra Doze, Philip H Elsinga, Aren van Waarde, et al.
Pageof 11